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0022-2836 © 2010 Elsevier Ltd.Open acceαβ T-cell receptors (TcRs) play a central role in cellular immune response.
They are members of the Ig superfamily, with extracellular regions of the α
and β chains each comprising a V-type domain and a C-type domain. We
have determined the ectodomain structure of an αβ TcR, which recognizes
the autoantigen myelin basic protein. The 2.0-Å-resolution structure reveals
canonical main-chain conformations for the Vα, Vβ, and Cβ domains, but the
Cα domain exhibits a main-chain conformation remarkably different from
those previously reported for TcR crystal structures. The global IgC-like fold
is maintained, but a piston-like rearrangement between BC and DE β-turns
results in β-strand slippage. This substantial conformational change may
represent a signaling intermediate. Our structure is the first example for the
Ig fold of the increasingly recognized concept of “metamorphic proteins.”Keywords: T-cell receptor; conformational change; crystal structure; signaling;
metamorphic proteinsEdited by I. WilsonIntroduction
CD8+ and CD4+ T cells detect peptide antigens,
presentedbymajor histocompatibility complex (MHC;
class I or class II) molecules, through αβ T-cell
receptors (TcRs) on their cell surface. The extracellular
region of αβ TcRs comprises an α chain and a β chain,s to be contacted
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ss under CC BY license. each consisting of Ig-like variable and constant
domains. The TcR Cα domain is notable in differing
from the classical IgC1 domain.1–3 Complementarity-
determining loops of the variable domain are respon-
sible for specific binding to peptide antigens upon
recognition of MHC molecules. The signal resulting
from this recognition event is transduced by CD3γɛ,
CD3δɛ, and CD3ζζ. There is substantial evidence from
a variety of functional studies indicating that the
constant domains of the TcR interface with CD3.4–9
Mutagenesis has demonstrated that the interactions of
CD3δɛ and CD3γɛ subunits with the TcR Cα and Cβ
domains, respectively, contribute to the stability and
function of the TcR–CD3 signaling complex.10 A series
of experiments from Gil et al. suggests that TcR
triggering requires the TcR–CD3 interface to accom-
modate large changes in the relative positions of the
TcR and CD3 components.11,12
Our studies of TcRs specific for a variety of
peptide–MHC complexes (pMHCs) have allowed us
Table 1. Data collection and refinement statistics for
X-ray crystallography
Data collection statisticsa
Resolution (Å) 30–2.0 (2.05–2.00)
Completeness (%) 91.7 (63.9)
Multiplicity 2.7 (1.9)
I/σI 20.2 (3.0)
Number of observations/
unique reflections
690,731/74,855
Rsym
b 5.1 (25.9)
Refinement statistics
Wilson B/average B 29.5/36.0
Number of non-H
atoms/waters
6958/802
Number of reflections 70,789 (3611)
RMSDc bonds/angles 0.014/1.5
Ramachandrand 89.2 9.6 0.5 0.7
Rcryst/Rfree
e (%) 20.0/24.3
B-factor
(Å2)
B-factor of
equivalent
domain in
RMSD with
JM22
(% α-carbon
829Alternative Conformation of T-Cell Receptorto sample TcR constant domain structures in a range
of crystal lattice environments.13–15 This has pro-
vided us with the opportunity to survey variation in
TcR constant domain structure. Here we present a
2.0-Å-resolution crystal structure of the extracellular
domains of a TcR (1F1E8hu) that recognizes the
human leukocyte antigenDR2bmolecule in complex
with amyelin basic protein (MBP) antigen. Compari-
sons of this unliganded TcR structure with those
previously reported for MHC-class-I-restricted and
MHC-class-II-restricted TcRs reveal a novel struc-
tural rearrangement for the α-chain constant
domain. The high-resolution crystal structure of
1F1E8hu provides the first structural evidence that
the TcR α-constant domain can adopt two very
different but stable conformations. This example of
“β-strand slippage” is indicative of structural
malleability in the TcR Cα domain, which may be
of functional relevance.JM22 (Å2) residues used)
1F1E8hu 35.8 34.4 2.1 (90)
1F1E8hu Vα 35.5 28.0 1.5 (96)
1F1E8hu Vβ 36.2 27.3 1.1 (98)
1F1E8hu Cα 36.4 52.5 2.3 (78)
1F1E8hu Cβ 35.4 37.0 0.6 (99)
RMSDs were calculated using the program SHP (D. I. Stuart,
unpublished).
a Data in parenthesis are for the highest-resolution shell.
b Rsym=σj|〈I〉− Ij|/σ〈I〉 where Ij is the intensity of the jth
reflection, and 〈I〉 is the average intensity.
c Root-mean-square deviation from ideal values.
d Values are expressed as the percentage of amino acids in the
“core,” “allowed,” “generously allowed,” and “disallowed”
regions, respectively.
e Five percent of data have been set aside for cross-validation
calculations.Results
The 1F1E8 TcR, cloned from a humanized
transgenic mouse,16 recognizes the autoantigen
MBP85–99 (MBP residues 85–99) presented by
human leukocyte antigen DR2b with the same fine
specificity as cognate human TcRs.17 To facilitate
protein production and crystallization of a soluble
form of 1F1E8, we exchanged its mouse constant
domains with those of a human TcR (JM22)
that has consistently provided high-resolution
structures.13,15 The linker regions between TcR
variable and constant domains in mouse and
human are relatively conserved, and formation of
the chimeric 1F1E8hu TcR introduces no residue
substitutions that are incompatible with structural
integrity. Biophysical experiments demonstrated
that the humanized 1F1E8hu TcR recognizes the
DR2b–MBP85–99 complex.18 In transgenic mice, we
have previously shown that replacing the human
TcR constant domains with those of the mouse
receptor does not alter the TcR recognition of the
DR2b–MBP85–99 complex.16
The structure of 1F1E8hu was determined by
molecular replacement and refined to a crystallo-
graphic R-value of 24% (Rfree=20%) using data up to
2.0 Å resolution (Table 1). There are two copies of
the molecule per crystallographic asymmetric unit
(Fig. 1a); for both of these copies, there is clear
electron density (representative electron density is
shown in Fig. 1b) for the variable and constant
regions of the α and β chains. The two copies of
1F1E8hu are identical in structure (RMSD of 0.3 Å on
100% equivalent α-carbons); copy 1 is used in the
following analysis (Fig. 1).
Variable domains
Both the α variable domain and the β variable
domain are similar to those in previously reported
TcR structures, with the α and β complementarity-
determining region (CDR) 1 and CDR2 loopsadopting canonical main-chain conformations.19 In
analyzing the variable domains, we were particu-
larly interested in the crystal structures of two
previously reported TcRs: Ob1A1220 and B7.21
1F1E8hu recognizes the same antigen as Ob1A12
(a TcR isolated from amultiple sclerosis patient with
a relapsing–remitting disease course; the Ob–MBP–
DR2b complex structure shows a distinctive TcR
binding mode positioned over the N-terminal
portion of the MBP peptide) and the human TcR
B7, which has a relatively high sequence identity to
1F1E8hu (59% and 56% for Vα and Vβ, respectively)
and typifies foreign antigen-reactive TcRs in its
pMHC-binding characteristics. Structural superpo-
sitions of 1F1E8hu on B7 and Ob1A12, respectively,
give RMSDs between Cα equivalents of 1.2 Å and
0.9 Å for the Vα domain, and Cα equivalents of 1.0 Å
and 0.9 Å for the Vβ domain. The buried surface
between the 1F1E8hu Vα domain and the 1F1E8hu
Vβ domain is 1486 Å2, which is very similar to those
of other TcRs (1450 Å2 in B7 and 1498 Å2 in
Ob1A12).
Since Ob1A12 and 1F1E8hu recognize the same
pMHC, we carried out a detailed comparison of the
six CDR loops, which determine the binding
characteristics of each TcR (Fig. 2b). The number
Fig. 1. Crystal contacts in the 1F1E8hu structure. (a) Both copies of the 1F1E8hu TcR are shown. The α chain is shown
in light gray, and the β chain is shown in dark gray. Residues involved in crystal contacts within the crystallographic
asymmetric unit (asu) are shown in red, and contacts between molecules in different asu's are depicted in green.
(b) Overlay of the Cα domains of 1F1E8hu (dark gray) and JM22 (light gray), electron density at 1σ illustrating the
shortened DE loop in 1F1E8hu, and residues 174–184 depicted in ball-and-stick. Carbons are highlighted in yellow,
oxygens are highlighted in red, and nitrogens are highlighted in blue. Cartoons were produced using PyMOL (http://
www.pymol.org).
830 Alternative Conformation of T-Cell Receptorand nature of many of the amino acids in the CDR
loops vary considerably between 1F1E8hu and Ob
(Fig. 2a). Main-chain conformations of the TcR α-
chain and β-chain CDR1 and CDR2 loops generally
correspond to one of three or four canonicalstructures defined by conserved residue motifs.19
The CDR1α, CDR2α, CDR1β, and CDR2β loops of
1F1E8hu each conform to one of these canonical
structures, whereas all four of the equivalent loops
of Ob1A12 do not. These differences in amino acid
Fig. 2. Comparison of 1F1E8hu and Ob1A12 TcR CDR loops. (a) Sequence alignment of Ob1A12 and 1F1E8hu TcR V
domains with CDR loops indicated. (b–g) Cα traces of Ob1A12 and 1F1E8hu TcR CDR1α (b), CDR1β (c), CDR2α (d),
CDR2β (e), CDR3α (f), and CDR3β (g) loops. The darker loop of each color is 1F1E8hu, and the lighter loop of each color is
Ob1A12. The Ob1A12 loops are taken fromHahn et al.20 Superpositions were made using SHP,22 and PyMOLwas used to
generate the figure.
831Alternative Conformation of T-Cell Receptorusage and main-chain conformation introduce
profound differences in the shape and electrostatic
footprint of the 1F1 TcR relative to those of Ob1A12,
consistent with the different recognition character-
istics of these two TcRs observed for serial alanine
substitution of the MBP peptide in T-cell stimulation
assays.17,18,23,24
Constant domains
The main-chain atoms of the β-chain constant
domain (Cβ) are superimposable on those of JM22,
which has a 100% sequence homology for the
constant domains [Protein Data Bank (PDB) code
1OGA],13 with the exception of minor changes in
one β-strand (discussed in the text below). How-
ever, the α-chain constant domain (Cα) shows a
large structural deviation from all previously
reported structures, including the identical se-
quence in JM22 (Fig. 3a–c). In these published
structures, the Cα domain adopts an unusual IgC-
like fold. β-Strands “A,” “B,” “E,” and “D” form
one sheet (bottom sheet) of the Cα domain, as in aconventional IgC domain, but strands “C,” “F,” and
“G” (top sheet), although linked to the bottom sheet
by a disulfide bond, pack only loosely against it,
leading to surface exposure of some hydrophobic
core residues25 (Fig. 3c). In 1F1E8hu, the main-chain
conformation of strands A and B and the AB loop
(residues 116–150) matches that of JM22 and all
other TcR structures; however, at the BC loop, the
sequence register between 1F1E8hu and JM22
shifts. Usually, the BC loop is 4 residues long; in
the 1F1E8hu structure, 11 residues contribute to a
significantly larger but flexible loop [of which
residues 151–157 (QTNVSQS) are disordered].
Although mobile, this region will occupy a signif-
icantly larger volume at the domain surface than
the standard BC loop (Fig. 3d). The residues
forming strand C in 1F1E8hu therefore differ from
those in all other TcR structures (e.g., JM22) (Fig.
3b); the sequence is effectively displaced towards
the N-terminus. Although the C strand in JM22 is
not involved in a classical acceptor–donor hydro-
gen-bond network, it adopts an extended β-strand-
like main-chain conformation; the equivalent
Fig. 3. Structural comparison of 1F1E8hu and JM22 TcRs. (a) Ribbon representation of the 1F1E8hu and JM22
structures colored according to the B-factor, where dark blue is the lowest (15 Å2) and deep red is the highest (75 Å2). (b)
Amino acid sequence for the human TcR α-chain constant domain. β-Strands are represented by arrows. The red broken
line indicates the disordered region in 1F1E8hu. Residues 159–181 are rainbow colored, reflecting equivalent residues in
the Cα domains of JM22 (c) and 1F1E8hu (d). (e) Overlay of the Cα domains of 1F1E8hu (dark gray) and JM22 (light gray),
and electron density at 1σ illustrating the shortened DE loop in 1F1E8. Cartoons were produced using PyMOL.
832 Alternative Conformation of T-Cell Receptorsecondary structural element in 1F1E8hu starts as a
short 310 helical turn, followed by an extended
chain. The CD loop is different in shape, length,
and, most interestingly, charge distribution (there is
an extensive hydrophobic patch on the 1F1E8hu
surface) due to the shift in residue usage (Fig. 3a).
Remarkably, the main-chain positions of the D
strand in 1F1E8hu and JM22 are similar, even
though the residues that form this part of thestructure differ [residues 172–176 (MRSMD) in
1F1E8hu; residues 164–168 (ITDKT) in JM22]. The
replacement of Ile164 by Arg173 at the start of
strand D contributes to the different CD loop
conformation. The main-chain and side-chain
atoms of residues Ser174 (Thr165), Met175
(Lys166), and Asp176 (Thr167) adopt similar posi-
tions in both structures, with no obvious distorting
effect on neighboring structural elements. The D
Fig. 4. Surface representations of the 1F1E8hu and JM22 Cα domains. (a) Cα domains of 1F1E8hu and JM22 are
shown in identical orientations. Green surfaces represent exposed hydrophobic residues. Electrostatic surface potentials
are shown in red for negative potentials (−20 kT) and in blue for positive potentials (+20 kT). (b) Rotation of (a) showing
the top sheet of the Cα domain. Surfaces were calculated using the program GRASP (http://trantor.bioc.columbia.edu/
grasp/).
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Fig. 5. α–β interface of the 1F1E8hu and JM22 constant domains. The Cα domain is shown in red, and the Cβ domain is
shown in blue. Strand D of the Cα domain and strand D of the Cβ domain are represented in ball-and-stick atoms; the rest
of the protein is shown in cartoon form.
834 Alternative Conformation of T-Cell Receptorstrand ends prematurely in 1F1E8hu compared to
JM22; a hydrogen bond between the side-chain
hydroxyl group of Ser179 and the side-chain
hydroxyl group of Ser181 stabilizes the shortened
DE loop (Figs. 1b and 3e). Interestingly, equivalent
serine residues (residues 169 and 171) of the γδ TcR
form a similar hydrogen bond in the connective DE
loop.26,27 In the JM22 structure, these serine
residues are some 6 Å apart in strand D, allowing
it to continue for another four residues before
forming a β-hairpin turn into strand E. An omit
map of this region of 1F1E8hu shows well-defined
density for all main-chain and side-chains atoms,
confirming the novel arrangement of the amino
acid residues (Figs. 1b and 3e). The truncation of the
β-hairpin in 1F1E8hu further affects the shape and
charge distribution of the TcR surface. In JM22, an
extra nine residues are used to form the DE
β-hairpin; short circuiting this loop allows the
residues of 1F1E8hu to get back in register with
those in JM22 at the point where the E strand of
1F1E8hu starts at Asn180. From Ser181 onwards,
the residue usage in 1F1E8hu and JM22 is con-
served, but variations in main-chain and side-chain
conformations result in significant changes in
surface characteristics (Fig. 4).
Overall, the structure of the 1F1E8hu Cα domain
maintains a global IgC-like scaffold, but reveals a
piston-like conformational change; from the BC turn
to the DE turn, the residue positions are completely
different, with many of those normally forming
strands becoming involved in interstrand loops and
vice versa (Fig. 3b–d). The Cα domain contains
several N-linked glycosylation sites, but none lies
at positions that could impede this structural
rearrangement. Although the core topology of the
1F1E8hu Cα domain remains similar to that of JM22
(RMSD of 2.3 Å for 78% α-carbon pairs), comparison
using the program GAP (which evaluates the
relative position of chemically identical residues in1F1E8hu and JM22; J. Grimes and D. I. Stuart,
unpublished program) reveals an RMSD of 8.7 Å for
equivalent residues. A very different set of residues
now contributes to the interface with the Cβ domain,
yet the hydrophobic character required for this
interaction25 is maintained (Fig. 4a). It has been
previously been noted that the Cβ domain must be
able to interface with at least two different surfaces:
the pre-TcR α subunit4 and the TcR α chain.
Comparison of 1F1E8hu and JM22 shows that Cα
interface changes are accommodated by relatively
small structural adjustments in the D strand of the
Cβ domain (Fig. 5), a region already seen to have
significant flexibility (as judged by crystallographic
B-factors) in previous structures (Fig. 3a).
The Cα domain has historically been the most
disordered region of the TcR, suggesting a tendency
to adopt different conformations. For example, the
Cα domains were omitted from the final models of
several TcR–pMHC structures due to lack of
electron density,28,29 and the initial structure deter-
mined for the isolated murine 2C TcR was devoid of
any clear electron density for the Cα domain.25
These examples of Cα domain disorder contrast with
the relatively well-ordered electron density in the
tightly abutting Cβ domains and suggest that some
crystals may have sampled more than one Cα
domain conformation. For the murine 2C TcR, a
single domain conformation was subsequently
stabilized by crystallization in a different space
group.25 Analysis of the average B-factor for each
domain of all TcRs solved to date confirms that the
Cα domain, when visualized, has the greatest
mobility (Table 1). This flexibility is particularly
pronounced in the top sheet (Fig. 3a). In both
crystallographic copies of the 1F1E8hu structure, the
Cα top sheet makes contact with neighboring
molecules in the crystal (Fig. 1a) and is well ordered
with an average B-factor of 36.4 Å2 (the overall B-
factor for 1F1E8hu is 35.8 Å2).
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Several distinctive features of the TcR Cα domain
may facilitate the “β-strand slippage” that we
observed in the 1F1E8hu structure. Firstly, the
number of amino acids between anchoring cysteine
residues is only 50, as opposed to 60–65 in the
classical IgC domain. Secondly, the otherwise
conserved Trp15 residue upstream of the first
cysteine is omitted in the TcR Cα domain. These
deviations from the normal IgC domain produce a
more loosely packed core, allowing for structural
rearrangement within the domain.25
In line with our findings, other groups have
reported similarly large conformational changes in
a range of proteins: firstly, the crystal structure of a
metastable dimeric form of the variable domain
from the cell surface adhesion molecule CD2.30 The
dimer results from segments of two polypeptide
chains intercalating to form two domains, each of
which remains similar to the conventional variable
domain fold. For the 1F1E8hu structure, there is no
such intercalation of domains, but rather β-strand
slippage. This phenomenon resembles the observa-
tion that ARNT (aryl hydrocarbon receptor nuclear
translocator) PAS-B (Per–Arnt–Sim B) can adopt an
alternative β-sheet register.31 The β-sheet surface in
ARNT PAS-B mediates protein–protein interac-
tions, and the authors speculate that the structural
malleability indicated by this β-strand slippage
maybe related to the flexibility required for binding
to several protein partners. Similarly, the spindle
assembly checkpoint protein Mad2 can adopt
either of two distinct conformations while main-
taining a large common substructure.32 More
drastically, the protein lymphotactin can adopt
two distinct folds in equilibrium to facilitate
multiple functional states.33 Our observation that
the 1F1E8hu Cα domain is intrinsically able to
adopt two conformational states raises the question
as to what role this structural plasticity plays in
TcR function. One very appealing theory is that
flexibility and/or conformational changes in the
TcR Cα domain could provide a mechanism to
allow it to adapt to binding CD3 and hence play its
role in TcR signaling.25,34,35
Experiments by other groups support the hypoth-
esis that the Cα domain could play a vital role in TcR
signal transduction. Kuhns and Davis have shown,
by mutagenesis of different Cα loops, that the CD3
contact region is likely to be located within the DE
loop.10 It is further noteworthy that residues
affected by the altered conformation of 1F1E8hu
have previously been identified as making crucial
contacts with CD3; the antibody H28-710 (which
binds Cα domain residues 150–177) prevents TcR–
CD3 interaction,5 and the association of CD3ζ with
TcR αβγδɛ is completely abolished by a single-point
mutation (phenylalanine to valine at position 195)
in the Cα domain.6 Gil et al. showed that, upon
antigen recognition, the CD3 complex undergoes a
conformational change to initiate T-cell signaling,12
and they postulated that this change could bepropagated through the TcR. Hence, any structural
rearrangement in the Cα domain may be transmit-
ted to CD3 and vice versa. Thus, our data on the
structural plasticity of the Cα domain are of direct
relevance to a number of hypotheses that have
proposed that a structural rearrangement in the
TcR–CD3 complex is necessary in early T-cell
signaling.36
The ability of certain proteins to adopt multiple
conformations is central tomany biological processes,
and the increasing number of examples of this
phenomenon has recently been characterized by the
term “metamorphic proteins.”37 The structure of
1F1E8hu reveals that the TcR Cα domain is also able
to adopt two very different stable conformations, a
fundamental property that is potentially central to
TcR function.
Methods
Protein expression, purification, and biophysical
characterization
The TcR Vα and Vβ regions were PCR amplified from
cDNA derived from the mouse 1F1E8 T-cell hybridoma.
These regions were then spliced by overlap extension to
human TcR Cα and Cβ regions, including C-terminal
extensions designed to assist the formation of an interchain
disulfide bridge (as previously reported for the structure of
JM22).13,18 PCR products for these α and β chains were
digested with NdeI and XhoI, cloned into pET-22b(+)
(Novagen), and separately expressed in Escherichia coli cells
(B834 for α chain and B834pRareLysS for β chain;
Novagen). The heterodimeric functional TcR (termed
1F1E8hu) was produced using previously described
protocols.13 In brief, the inclusion bodies resulting from
the expression of the TcR α and β chains were mixed and
dialyzed in the presence of a refolding buffer containing a
redox couple, and refolded protein was then purified by
column chromatography (anion exchange followed by gel
filtration).
Prior to crystallization, the refolded protein sample was
subjected to quality control by means of SDS-PAGE, mass
spectrometry, and dynamic light scattering. Because the
correctly refolded protein contains an interchain disulfide
bond, all these techniques were performed under reducing
and nonreducing conditions by the addition or omission of
β-mercaptoethanol from the sample. The predicted mo-
lecular mass of the correctly refolded protein is 54,423 Da.
SDS-PAGE analysis of the purified sample clearly showed
the presence of a single 53-kDa band, which, upon the
addition of reducing agent, ran as two distinctly separate
bands of ∼26 kDa and ∼29 kDa (with similar intensities),
concurrent with the 1F1E8hu α and β chains, respectively.
Mass spectrometry further verified the presence of
correctly refolded heterodimeric TcR; the nonreduced
sample had a molecular mass of 54,416 Da and, under
reducing conditions, the presence of equimolar amounts of
α chain (25,598 Da) and β chain (28,825 Da) with the
expectedmolecularmasseswas confirmed. Dynamic light-
scattering experiments were performed on the nonreduced
sample to ensure that no aggregation of the protein sample
had occurred; this technique, although not as sensitive,
confirmed a homogeneous solution containing nonaggre-
gated protein with a calculated mass very similar to that of
1F1E8hu.
836 Alternative Conformation of T-Cell ReceptorCrystallization and structure determination
Crystallization trials were carried out using previously
reported robotic technologies and protocols.15,29 1F1E8hu
was crystallized by vapor diffusion at 10mg/ml using 200-
nl sitting drops at 20 °C. The precipitant solution contained
0.3 mM (NH4)2 hydrogen citrate and 20% wt/vol
polyethylene glycol 3000. The resulting crystals were
plate-like with dimensions of 100 μm×50 μm×10 μm.
The crystals were cryoprotected in mother liquor contain-
ing 20% glycerol and cooled to ∼100 K. X-ray data were
collected at the European Synchrotron Radiation Facility
(Grenoble, France) on beamline id14-EH1 and processed
using the program package HKL2000.38 A molecular
replacement solution was readily found using an MHC-
class-I-restricted TcR (PDB code 1BD2) as initial search
model21 in Phaser.39 The structure was built using O,40
refined with REFMAC,41 and checked using the program
PROCHECK.42 Two copies of the 1F1E8hu heterodimer
were present in the crystallographic asymmetric unit,
designated as copies 1 and 2. Superposition of copies 1 and
2 showed that they are near identical (RMSD of 0.3 Å on
100% equivalent α-carbons), with only a few differences in
side-chain positions exposed to the solvent. For this reason,
copy 1 was used for the calculations and figures in this
work, unless otherwise stated.
Accession numbers
Coordinates and structure factors have been deposited
in the PDB under accession number 3MFF.Acknowledgements
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